PMC:7696151 / 11159-11349 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"304","span":{"begin":5,"end":13},"obj":"Species"},{"id":"305","span":{"begin":131,"end":136},"obj":"Species"},{"id":"326","span":{"begin":187,"end":190},"obj":"Chemical"}],"attributes":[{"id":"A304","pred":"tao:has_database_id","subj":"304","obj":"Tax:9606"},{"id":"A305","pred":"tao:has_database_id","subj":"305","obj":"Tax:11676"},{"id":"A326","pred":"tao:has_database_id","subj":"326","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"udy, patients who had received HAART stopped taking it four weeks before the clinical trial’s outset. After 16 weeks, total plasma HIV-1 RNA levels were reduced in both the ZDV group and HCQ"}